General Range
ZIFROCIN-250
Price on request/100 · MOQ 100 boxes
ZIFROCIN-250 Tablets by Fortune Labs contain Azithromycin 250 mg, a macrolide antibiotic used to treat various infections caused by susceptible bacteria. Azithromycin works by inhibiting bacterial protein synthesis, helping control bacterial growth and infection. ZIFROCIN-250 may be prescribed for selected respiratory tract infections, throat infections, sinusitis, ear infections, and certain skin infections when clinically appropriate. Available in convenient 1 × 6 tablet blister packaging, ZIFROCIN-250 is part of Fortune Labs' pharmaceutical product portfolio. Fortune Labs offers PCD Pharma Franchise and pharmaceutical distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. This prescription antibiotic should be used only under medical supervision to ensure appropriate treatment and responsible antibiotic use.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Azithromycin 250 mg
- Packaging Type
- Blister Pack
- Packaging Size
- 1 × 6
- Dosage Form
- Tablet
- Treatment
- Bacterial respiratory tract infections, throat infections, sinusitis, ear infections, certain skin and soft tissue infections, and other infections ca
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
